You haven't searched anything yet.
Who we are
REGENXBIO is an exceptional place to work. You'll have the opportunity to collaborate with some of the best and the brightest people, touch amazing science, and be a part of extraordinary plans. Our core values: Trust, Accountability, Perseverance, and Innovation drive everything we do. We aim to bring these values to life every day with all that we do, and we believe that what we do matters - to patients, to their families, and to their communities.
The Opportunity
REGENXBIO is currently searching for a Gene Therapy Manufacturing Supervisor (Upstream) to help us build our team! As Gene Therapy Manufacturing Supervisor, you will play a critical role in helping to establish REGENXBIO’s first internal GMP BDS and FDP clinical and commercial AAV gene therapy manufacturing capability. As a member of the highly engaged and collaborative Manufacturing Operations team, you will have the unique opportunity to start-up an agile, multi-product, single-use facility. You will play an important role in leading the establishment of new processes, procedures and ways of working, as well as performing manufacturing process related tasks and unit operations within Upstream Manufacturing.
\nWhat You'll Be Doing:
Why should you apply?
By joining REGENXBIO, you will have the opportunity to be a part of a growing company and incredible team passionate about developing novel AAV gene therapy products to our patients.
We offer a comprehensive and competitive benefit plan which includes market-competitive salaries, an annual bonus program, education assistance, retirement plan with employer match, stock options at all levels, summer hours and more!
In addition, professional development is important to us. By joining our team, you’ll have the opportunity the be exposed to challenging projects and development resources to help you grow personally and professionally.
Full Time
Durable Manufacturing
$98k-126k (estimate)
05/04/2024
07/03/2024
regenxbio.com
ROCKVILLE, MD
200 - 500
2009
Public
VURGHUN AHMADOV
$500M - $1B
Durable Manufacturing
REGENXBIO research and develops adeno-associated viral gene therapies for treatment of lysosomal storage disorders and ocular diseases.